Abstract:Pancreatic and duodenal homeobox-1 (PDX-1) is a homeodomain-containing transcription factor that plays a critical role in pancreatic development, beta-cell differentiation, maintenance of normal beta-cell function and tumorigenesis. PDX-1 is subjected to extensive post-translational modifications for its stability, subcellular location and transactivity. We report here that PDX-1 expression is up-regulated by p38 MAP kinase. Antibody array screen identified p38 as a candidate PDX-1-interacting protein in GFP-PDX-1 stable HEK293 cells. The p38-PDX-1 interaction was confirmed by immunoprecipitation/Western blotting analysis in both transient transfection system of HEK293 cells and endogenous system of beta-TC-6 cells stimulated by glucagon-like peptide 1 (GLP-1). Co-transfection of p38 with PDX-1 resulted in increased PDX-1 expression in HEK293 cells, which was accompanied by a decreased PDX-1 ubiquitination. Mass spectrometry analysis showed that Ser 268 of human PDX-1 was phosphorylated in GFP-PDX-1 stable HEK293 cells. Functional mutagenesis analysis showed that mutation of Ser 269 of mouse PDX-1 (corresponding to Ser 268 of human PDX-1) into nonphosphorylatable alanine abolished the stabilizing effect of p38 on PDX-1, which was in line with enhanced PDX-1 ubiquitination and shortened half-life of PDX-1. p38 showed kinase activity towards PDX-1 in vitro, suggesting that Ser 269 is a potential p38-regulated phosphorylation site within PDX-1. GLP-1-stimulated PDX-1 expression was accompanied by p38 kinase activation in mouse insulinoma beta-TC-6 cells and p38 inhibitor SB202190 inhibited GLP-1-stimulated PDX-1 expression with accompanied inhibition of p38 kinase activation. Taken together, our studies indicated that p38 MAP kinase is a positive regulator of PDX-1 stability and that p38 exerts its stabilizing effect on PDX-1 through a phosphorylation-dependent inhibition of PDX-1 ubiquitination.

F-box only protein 31 (FBXO31) negatively regulates p38 mitogen-activated protein kinase (MAPK) signaling by mediating lysine 48-linked ubiquitination and degradation of …

F-Box Only Protein 31 (FBXO31) Negatively Regulates P38 Mitogen-activated Protein Kinase (MAPK) Signaling by Mediating Lysine 48-Linked Ubiquitination and Degradation of Mitogen-activated Protein Kinase Kinase 6 (MKK6)

Overexpression of F‐box Only Protein 31 Predicts Poor Prognosis and Deregulates P38α‐ and JNK‐mediated Apoptosis in Esophageal Squamous Cell Carcinoma

FBXO46 negatively regulates p53 activity by stabilizing Mdm2

p38-regulated FOXC1 stability is required for colorectal cancer metastasis.

The SCFFBXO46 ubiquitin ligase complex mediates degradation of the tumor suppressor FBXO31 and thereby prevents premature cellular senescence

FBXO38 is dispensable for PD-1 regulation

FBXL20-mediated Vps34 ubiquitination as a p53 controlled checkpoint in regulating autophagy and receptor degradation

FBXO22 inhibits colitis and colorectal carcinogenesis by regulating the degradation of the S2448-phosphorylated form of mTOR

New Tumor Suppressor Cxxc Finger Protein 4 Inactivates Mitogen Activated Protein Kinase Signaling

FBXO38 deficiency promotes lysosome-dependent STING degradation and inhibits cGAS–STING pathway activation

Function and regulation of F-box/WD repeat-containing protein 7

The F-box-only protein 44 regulates pregnane X receptor protein level by ubiquitination and degradation

P38 MAP Kinase Interacts with and Stabilizes Pancreatic and Duodenal Homeobox-1

FBXO38 mediates PD-1 ubiquitination and regulates anti-tumour immunity of T cells

USP18 negatively regulates NF-κB signaling by targeting TAK1 and NEMO for deubiquitination through distinct mechanisms

JFK, a Kelch domain-containing F-box protein, links the SCF complex to p53 regulation

Global identification of phospho-dependent SCF substrates reveals a FBXO22 phosphodegron and an ERK-FBXO22-BAG3 axis in tumorigenesis

Skp2 Attenuates Nf-Kappa B Signaling By Mediating Ikk Beta Degradation Through Autophagy

JTV1 co-activates FBP to induce USP29 transcription and stabilize p53 in response to oxidative stress

FBXL6 degrades phosphorylated p53 to promote tumor growth